Biotechnology
Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2020 Financial Results
HONG KONG, Nov. 21, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release unaudited financia...
2019-11-21 20:00
5769
Global Cord Blood Corp Comments on New Regulation
HONG KONG, Nov. 20, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today commented on a new regulation related to companies in ...
2019-11-20 20:00
5427
RhoVac Reports Interim Results on Immunological Response with RV001
STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- Today, 18th November 2019, RhoVac AB ("RhoVac") reports interim results from ongoing immunological studies at University of Tübingen,Germany concluding that treatment with RV001 can activate CD4+ T-cells and also CD8+ T-cells. In July 2019 RhoVac publishe...
2019-11-18 17:13
983
Unprecedented Gathering of Asia Pacific Medical Societies to Respond to the Impact of Antibiotic Resistance on All People
BANGKOK, Nov. 17, 2019 /PRNewswire/ -- In anticipation of World Antibiotic Awareness Week (18-24 November) the Antimicrobial Resistance (AMR) Summit Expert Group and the Antimicrobial Stewardship (AMS) Working Group convened in Bangkok, Thailand, in a first-ever regional effort to combat the 'sile...
2019-11-17 12:00
2181
World's First Candidate Antibody Treatment for Yellow Fever, Developed by Tychan, Tested Safe and Effective in Human Volunteers
* Phase 1A/1B safety and efficacy trials in Singapore completed within 8 months * TY014 also found to prevent vaccine related adverse effects in vaccinated volunteers SINGAPORE, Nov. 14, 2019 /PRNewswire/ -- Tychan's first-in-class monoclonal antibody candidate treatment for Yellow Fever (YF)...
2019-11-14 11:07
1252
Delivering Greater Throughput And Decreased Turnaround Time For Research Labs Is The Focus Of Leica Biosystems Next Generation Digital Pathology Scanner
VISTA, Calif., Nov. 14, 2019 /PRNewswire/ -- Leica Biosystems, the global leader in pathology workflow solutions, announced today that it has launched the Aperio GT 450, its next generation digital pathology scanner. The Aperio GT 450, labeled as research use only, offers continuous rack loading ...
2019-11-14 08:00
1133
Merck Licenses CRISPR Gene-Editing Technology to Evotec
-- License to accelerate research, enable testing and development of new drugs DARMSTADT, Germany, Nov. 12, 2019 /PRNewswire/ -- Merck, a leading science and technology company, today announced that it has signed a license agreement providingEvotec SE access to Merck's foundational CRISPR intelle...
2019-11-12 21:00
2008
Neurovalens Unveils Modius SLEEP, a Genius Next-Gen Device Powered by Neuroscience to Optimize Sleep Health and Address the Global Sleep Crisis, Without Medication
SAN DIEGO, Nov. 12, 2019 /PRNewswire/ -- Neurovalens
2019-11-12 20:18
1887
AGC Biologics' $18m Investment in Seattle and Denmark Facilities Strengthens Global Footprint
SEATTLE, Nov. 12, 2019 /PRNewswire/ -- AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today that their development and manufacturing capabilities at theirSeattle, Washington and Copenhagen, Denmark facilities will be expanded, as part of...
2019-11-12 20:00
1893
ATAI Life Sciences and Cyclica launch joint venture to revolutionize drug development for mental health disorders
BERLIN and TORONTO, Nov. 11, 2019 /PRNewswire/ -- ATAI Life Sciences AG, a global biotech platform that envisions an end to mental illnesses, andCyclica Inc., a leading biotechnology company that leverages artificial intelligence and computational biophysics to streamline the drug discovery proce...
2019-11-11 21:45
1181
Global Cord Blood Corporation Appoints Mr. Jack Chow As an Independent Non-executive Director
HONG KONG, Nov. 11, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced the appointment of a new independen...
2019-11-11 19:30
4780
Akeso, Inc. Completes Series-D Private Financing for US$150 Million
ZHONGSHAN, China, Nov. 9, 2019 /PRNewswire/ -- Akeso, Inc. (hereinafter referred to as "Akeso") announced the completion of its Series-D private financing for nearlyUS$150 million, which was co-led in investment by Loyal Valley Capital ("LVC") and Sino Biopharmaceutical Co. Ltd. ("Sino Biopharm")...
2019-11-09 00:43
2879
Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company
MADISON, Wisconsin, Nov. 8, 2019 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced that it has completed itspreviously announced combination with Genomic Health, Inc. (NASDAQ: GHDX). "Today marks a pivotal step toward building the world's leading advanced cancer diagnostics co...
2019-11-08 21:24
6721
Enzene Opens its First Continuous Biologics Manufacturing Facility With a Promise to Disrupt the mAb Manufacturing Cost
PUNE, India, Nov. 7, 2019 /PRNewswire/ -- Enzene Biosciences today formally opened its first fully connected continuous Biologics manufacturing facility in Pune, India. This first-of-its-kind facility was built in half the time as compared to the conventional biologics manufacturing plants. The s...
2019-11-07 21:02
1506
TOT BIOPHARM (1875.HK) Proceeded with IPO raising over HK$500 million
HONG KONG, Nov. 7, 2019 /PRNewswire/ -- A clinical-stage biopharmaceutical company with full industry value chain capabilities, TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Company", together with its subsidiaries, the "Group", stock code: 1875) was well received by the capi...
2019-11-07 19:04
6779
First Asia-Pacific hospital treats patients with RayStation and Radixact
SUNNYVALE, California, Nov. 7, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) –Thailand's Lopburi Cancer Hospital, a center of excellence for cancer treatment, is the first in theAsia-Pacific region to clinically use the combination of RaySearch's treatment planning system RayStation® w...
2019-11-07 09:00
2390
EpiVax Announces Publication of Antigen-Specific Tolerance Induction by Tregitope in Nature Scientific Reports
PROVIDENCE, Rhode Island, Nov. 6, 2019 /PRNewswire/ -- EpiVax, Inc. ("EpiVax"), a pioneer in immunoinformatics innovation, announces the publication of "Therapeutic administration of Tregitope-Human Albumin Fusion with Insulin Peptides to promote Antigen-Specific Adaptive Tolerance Induction" inS...
2019-11-06 18:01
1500
Nanoform Wins the CPhI Excellence in Pharma Award for Formulation
HELSINKI, Nov. 6, 2019 /PRNewswire/ -- Nanoform, an innovative medicine enabling nanotechnology company, has won the Excellence in Pharma Award for Formulation at the prestigious CPhI Pharma Awards. Receiving this highly contested prize is an acknowledgement of Nanoform's commitment to innovation...
2019-11-06 17:21
1159
Wiley Partners With Editage to Enhance and Expand Services for Authors
LONDON, Nov. 6, 2019 /PRNewswire/ -- John Wiley & Sons Inc. is pleased to announce a new partnership with Editage, a leading global scholarly communications brand by Cactus Communications (CACTUS), to enhance and expand the services available from Wiley Editing Services. This partnership enables ...
2019-11-06 11:00
2662
Boehringer Ingelheim Applauded by Frost & Sullivan for Continuing to Lead the Bio-CDMO Market with Its Cutting-edge Innovation
LONDON, Nov. 5, 2019 /PRNewswire/ -- Based on its recent analysis of the global biologics contract development and manufacturing organization (CDMO) market, Frost & Sullivan recognises the biopharmaceutical contract development and manufacturing business ofGermany-headquartered Boehringer Ingelhe...
2019-11-05 21:00
1018
Week's Top Stories
Most Reposted
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
[Picked up by 325 media titles]
2024-05-17 07:00Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 319 media titles]
2024-05-15 12:00
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 306 media titles]
2024-05-16 15:00
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 276 media titles]
2024-05-16 09:39
Trip.com Group and Rezdy Join Forces to Offer New Travel Experiences Around the World
[Picked up by 229 media titles]
2024-05-14 18:07Most Read
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
2024-05-15 12:00
10592
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
2024-05-16 15:00
8993
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
2024-05-16 09:39
8504
Casio to Release G-SHOCK-Surfrider Foundation Collaboration
2024-05-15 09:00
7929
Traveloka strengthens sustainability pledge as world's first Platinum Sponsor of GSTC
2024-05-13 16:42
7333
